PNV 2.59% $2.38 polynovo limited

Ann: Final Patient enrolled in BARDA Feasibility Burn Trial, page-9

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,201 Posts.
    lightbulb Created with Sketch. 114
    Wonder why is expanded out to 15 patients? Thought it was a 10 patient feasibility trial followed by approx 150 patient full FDA trial. Will take longer than 2020 to recruit those numbers based on time taken to recruit 15 across 4 centres, albeit more centres will be involved in the full trial.
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.